Exelixis (EXEL) Stock Price Today & Analysis

Valuation
Earnings Per Share
Income Statement
Dividend
Solvency
About Exelixis
Exelixis, Inc., a biotechnology company strong focus on discovering, developing, and commercializing innovative therapies for treating cancer, the company has made significant strides in advancing its pipeline of targeted oncology treatments. Exelixis is renowned for its flagship drug, Cabometyx (cabozantinib), which has gained approvals for various cancer indications, demonstrating the company's dedication to improving patients' lives. Through strategic collaborations, cutting-edge research, and a commitment to scientific excellence, Exelixis continues to be at the forefront of delivering breakthrough therapies in the fight against cancer.
FAQ
- Download the Gotrade app from the App Store or Google Play.
- Create an account and complete KYC.
- Make a deposit.
- Search for the code "EXEL", then tap "Trade".
- Tap the "Buy" button.
- Enter the amount you want to buy. You have two options:
- Buy EXEL by number of shares.
- Buy fractional shares in dollars, starting from $1.
- Swipe up to confirm your order—done!
- Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
- Review revenue and earnings growth.
- Check margins and cash flow.
- Evaluate business outlook and the company's position within its industry.




